Background
New filtration markers, including β-trace protein (BTP) and β2-microglobulin (B2M), may, similar to cystatin C, enable a stronger prediction of mortality compared to serum creatinine-based estimated glomerular filtration rate (eGFRcr). We sought to evaluate these mortality associations in a representative sample of US adults.
Study Design
Prospective cohort study.
Setting & Participants
6445 adults age ≥ 20 years from the Third National Health and Nutrition Examination Survey (1988–1994) with mortality linkage through December 31, 2006.
Predictors
Serum cystatin C, BTP, and B2M and eGFRcr categorized into quintiles, with the highest quintile (lowest for eGFRcr) split into tertiles (sub-quintile Q5a–Q5c).
Outcomes
All-cause, cardiovascular disease, and coronary heart disease mortality.
Measurements
Demographic and multivariable adjusted Cox proportional hazard models.
Results
During follow-up, 2392 deaths (cardiovascular, 1079; coronary heart disease, 605) occurred. All four filtration markers were associated with mortality risk after adjusting for demographics (p-trend<0.02). Adjusted for mortality risk factors, compared to the middle quintile, the highest sub-quintiles for cystatin C (Q5c: HR, 1.94; 95% CI, 1.43–2.62), BTP (Q5c: HR, 2.14; 95% CI, 1.56–2.94), and B2M (Q5c: HR, 2.58; 95% CI, 1.96–3.41) were associated with increased all-cause mortality risk while the association was weaker for eGFRcr (Q5c: HR, 1.31; 95% CI, 0.84–2.04). Associations persisted for the novel markers and not for eGFRcr at eGFRcr ≥60 mL/min/1.73 m2. Trends were similar for cardiovascular disease and coronary heart disease mortality.
Limitations
Single measurements of markers from long-term stored samples.
Conclusions
The strong association of cystatin C with mortality compared to serum creatinine estimates is shared by BTP and B2M. This supports the utility of alternative filtration markers beyond creatinine when improved risk prediction related to decreased GFR is needed.